Lysophospholipid Metabolism and Signalling in Non-Alcoholic Fatty Liver Disease.
Folia Med (Plovdiv)
; 64(1): 7-12, 2022 Feb 28.
Article
em En
| MEDLINE
| ID: mdl-35851901
ABSTRACT
Non-alcoholic liver disease (NAFLD) constitutes a global health pandemic. It is estimated that about 25% of the world's population suffers from NAFLD. In the long-term, a subgroup of the patients can develop inflammation and fibrosis. The end result in some cases is cirrhosis and even liver-related death. The epidemiology and natural history of NAFLD lead to extreme financial costs.
Palavras-chave
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Hepatopatia Gordurosa não Alcoólica
Limite:
Humans
Idioma:
En
Revista:
Folia Med (Plovdiv)
Ano de publicação:
2022
Tipo de documento:
Article
País de afiliação:
Grécia